Article

Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes

2023-08-16

Abstract excerpt

<h4>Aim: </h4> To investigate whether polypharmacy and comorbidities conveyed more risk of adverse health outcomes following COVID-19 infection in people with type 1 diabetes (T1DM) or type 2 diabetes (T2DM). Materials and methods: The Greater Manchester Care Record (GMCR) is an integrated database of electronic health records containing data collected from 433 general practices in Greater Manchester. Baseline dem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0069da5f-d150-5ebe-b321-9fe91398afad
DOI: 10.1101/2023.08.12.23294016

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetesDOI 10.1101/2023.08.12.23294016Read

Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Whole Population StudySemantic proximity Read

COVID-19 Disease in People with Diabetes in Scotland: Incidence, Severity and Risk Stratification Using Matched Case-Control and Prospective Cohort StudiesSemantic proximity Read

Risk Phenotypes of Diabetes and Association with COVID-19 Severity and Death – A Living Systematic Review and Meta-AnalysisSemantic proximity Read

Multimorbidity, Polypharmacy, and COVID-19 infection within the UK Biobank cohortSemantic proximity Read

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careSemantic proximity Read

Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Semantic proximity Read

GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusSemantic proximity Read

Clinical Characteristics and Risk Factors for Disease Severity and Mortality of COVID-19 Patients with Diabetes Mellitus in Kazakhstan: A Nationwide StudySemantic proximity Read

Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.Semantic proximity Read

Microvascular Disease and Severe COVID-19 Outcomes in UKBiobank Diabetic CohortSemantic proximity Read

Comorbidity Burden among Adults with Symptomatic COVID-19 Illness: A Cross-Sectional StudySemantic proximity Read

Insulin Treatment Increased Fatality in COVID-19 Patients with DiabetesSemantic proximity Read